DocDollars

Grifols Shared Services North America, Inc.

CA · United States · Reporting entity ID 100000000233

Total reported 2019–2025
$10.2M
#482 of 2,960 reporting companies — 0% of all reported industry payments
$1.36M in general payments across 1,411 records, plus $8.88M in research funding across 162 records.

How it breaks down

General payments $1,361,493
Research funding $8,879,075

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Grifols Shared Services North America, Inc. reported $10.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #482 of 2,960 reporting companies. 87% of that was research funding and 13% general payments such as consulting, speaking, food and travel. 1,411 general payment records and 162 research records were filed.

Common questions about Grifols Shared Services North America, Inc.

How much has Grifols Shared Services North America, Inc. paid US doctors?

Grifols Shared Services North America, Inc. reported $10,240,568 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,361,493 in general payments, $8,879,075 in research funding.

How does Grifols Shared Services North America, Inc. rank among drug and device companies?

It ranks #482 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Grifols Shared Services North America, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.